Brian J. Leibowitz
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 17
- Cancer Cells and Metastasis 10
- Cancer-related Molecular Pathways 9
-
- PI3K/AKT/mTOR signaling in cancer 3
- DNA Repair Mechanisms 2
- Co-authors
- Jian Yu (29 shared papers)Lin Zhang (21 shared papers)Wei Qiu (4 shared papers)Joel S. Greenberger (10 shared papers)Wei Liang (6 shared papers)Michael W. Epperly (10 shared papers)Tao Cheng (2 shared papers)Wendie S. Cohick (3 shared papers)
- Journals
- Cancer Research (3 papers)Oncogene (3 papers)Scientific Reports (3 papers)Proceedings of the National Academy of Sciences (2 papers)Cancers (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Brian J. Leibowitz
35 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Oncology 373
- Cancer Research 173
- Radiology, Nuclear Medicine and Imaging 245
- Molecular Biology 593
- Immunology 135
Countries citing papers authored by Brian J. Leibowitz
This map shows the geographic impact of Brian J. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Leibowitz more than expected).
Fields of papers citing papers by Brian J. Leibowitz
This network shows the impact of papers produced by Brian J. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Leibowitz. The network helps show where Brian J. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian J. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 211 | |
| 2 | 2009 | 118 | |
| 3 | 2011 | 101 | |
| 4 | 2020 | 87 | |
| 5 | 2010 | 81 | |
| 6 | 2014 | 73 | |
| 7 | 2016 | 72 | |
| 8 | 2011 | 69 | |
| 9 | 2015 | 68 | |
| 10 | 2015 | 44 | |
| 11 | 2018 | 42 | |
| 12 | 2015 | 42 | |
| 13 | 2005 | 34 | |
| 14 | 2021 | 29 | |
| 15 | 2023 | 29 | |
| 16 | 2020 | 27 | |
| 17 | 2021 | 26 | |
| 18 | 2009 | 26 | |
| 19 | 2014 | 25 | |
| 20 | 2022 | 20 |
About Brian J. Leibowitz
Brian J. Leibowitz is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Effects of Radiation Exposure (10 papers), Cancer-related Molecular Pathways (9 papers), Cancer Research and Treatments (5 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (373 citations), Cancer Research (173 citations), Radiology, Nuclear Medicine and Imaging (245 citations), Molecular Biology (593 citations) and Immunology (135 citations). Brian J. Leibowitz has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jian Yu, Lin Zhang, Wei Qiu, Joel S. Greenberger, Wei Liang, Michael W. Epperly, Tao Cheng, Wendie S. Cohick, Hongtao Liu and Robert E. Schoen. Their work appears in journals such as Cancer Research, Oncogene, Scientific Reports, Proceedings of the National Academy of Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.